Acceptable single screening test for celiac disease. IgA testing recommended to identify IgA deficiency. Use IgA test in individuals who are IgA competent. May be useful in diagnosing children <2 years who test negative for tTG and EMA antibodies. May aid in monitoring adherence to gluten-free diet. Celiac Disease Reflexive Cascade (2008114) or Tissue Transglutaminase (tTG) Antibody, IgA (0097709) is the preferred test for screening patients with suspected celiac disease.

Acceptable single screening test for celiac disease. IgA testing recommended to identify IgA deficiency. Use IgG test in individuals who are IgA deficient. May be useful in diagnosing children <2 years who test negative for tTG and EMA antibodies. May aid in monitoring adherence to gluten-free diet. Celiac Disease Reflexive Cascade (2008114) or Tissue Transglutaminase (tTG) Antibody, IgG (0056009) is the preferred test for screening patients with suspected celiac disease.

Indicator of adrenal androgen production. Aids in the investigation of virilizing endocrinopathies in conjunction with other sex steroids. Not recommended for initial evaluation of polycystic ovarian syndrome.

May aid in the diagnosis of dengue when timing of infection is uncertain. In endemic regions, recommend co-testing for other arthropod-borne viruses including chikungunya and Zika due to overlapping symptoms.

May be used to diagnose dengue during acute phase of disease (>5 days after symptom onset). In endemic regions, recommend co-testing for other arthropod-borne viruses including chikungunya and Zika due to overlapping symptoms.

Evaluate the ability of a patient to produce antibody to pure protein vaccines (diphtheria and tetanus) and protein conjugated bacterial (H. influenza) vaccines after vaccination to rule out antibody deficiency.

May aid in evaluating the prognosis of malignancy in a variety of tumor specimen types. For cell cycle and DNA ploidy studies in products of conception specimens, refer to Products of Conception, Ploidy by Flow Cytometry (2006178).

Confirm current or recent infection with group A Streptococcus in patients suspected of having a nonsuppurative complication such as acute glomerulonephritis (AGN) or acute rheumatic fever (ARF). DNase-B Antibody (0050220) and Streptolysin O Antibody (ASO) (0050095) are generally ordered concurrently. Preferred test for rheumatic chorea since it remains elevated longer.

Detect and document maternal drug use during approximately the last trimester of a full term birth. To test for marijuana metabolite, see Marijuana Metabolite, Umbilical Cord Tissue, Qualitative (3000256).

Useful for general screening in contexts of compliance and/or abuse. For follow-up testing of a presumptive result, confirmatory testing by mass spectrometry is recommended. For automatic reflex testing on all presumptive positives, Drug Panel 7, Urine - Screen with Reflex to Confirmation/Quantitation (0092184) is recommended.

Useful for general screening in contexts of compliance and/or abuse. For follow-up testing of a presumptive result, confirmatory testing by mass spectrometry is recommended. For automatic reflex testing on all presumptive positives, Drug Panel 7A, Urine - Screen with Reflex to Confirmation/Quantitation (0092185) is recommended.

Useful for general screening in contexts of compliance and/or abuse. For follow-up testing of a presumptive result, confirmatory testing by mass spectrometry is recommended. For automatic reflex testing on all presumptive positives, Drug Panel 9, Urine - Screen with Reflex to Confirmation/Quantitation (0092186) is recommended.

Useful for general screening in contexts of compliance and/or abuse. For follow-up testing of a presumptive result, confirmatory testing by mass spectrometry is recommended. For automatic reflex testing on all presumptive positives, Drug Panel 9A, Urine - Screen with Reflex to Confirmation/Quantitation (0092187) is recommended.

• Use for infant drug testing when only amphetamine-based stimulant exposure is of clinical interest or when quantity of meconium available for testing is very small (eg, <1 g).
• Preferred test is Drugs of Abuse Panel, Meconium - Screen with Reflex to Confirmation/Quantitation (0092516).

• Use for infant drug testing when only benzodiazepine exposure is of clinical interest or when quantity of meconium available for testing is very small (eg, <1 g).
• Preferred test is Drugs of Abuse Panel, Meconium - Screen with Reflex to Confirmation/Quantitation (0092516).

• Use for infant drug testing when only cannabinoid (marijuana) exposure is of clinical interest or when quantity of meconium available for testing is very small (eg, <1 g).
• Preferred test is Drugs of Abuse Panel, Meconium - Screen with Reflex to Confirmation/Quantitation (0092516).

• Use for infant drug testing when only methadone exposure is of clinical interest or when quantity of meconium available for testing is very small (eg, <1 g).
• Preferred test is Drugs of Abuse Panel, Meconium - Screen with Reflex to Confirmation/Quantitation (0092516).

• Use for infant drug testing when only opiate exposure is of clinical interest or when quantity of meconium available for testing is very small (eg, <1 g).
• Preferred test is Drugs of Abuse Panel, Meconium - Screen with Reflex to Confirmation/Quantitation (0092516).

Preferred meconium test to detect and document maternal drug use during pregnancy approximately the last trimester of a full-term birth. Targeted single-drug class testing is appropriate if only a particular drug class or classes are of clinical interest, or when quantity of meconium available for testing is very small (eg <1g).

Order ONLY if previous DMD gene deletion/duplication testing did not identify a causative variant. Recommended first-tier tests are DMD Deletion/Duplication with Reflex to Sequencing (2011241) or DMD Deletion/Duplication (2011235).

Provide Feedback on ARUP Lab Test Directory

*I want to provide feedback regarding:Please select a feedback type

*Test Number:Please enter a test name or number

Please type your message. If you are reporting a problem, please indicate what you
were trying to do when the problem occurred, what you expected to happen, and what actually happened:*CommentPlease enter a comment